Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AXCELIS TECHNOLOGIES INC Director's Dealing 2017

Nov 10, 2017

31374_dirs_2017-11-09_80059603-af0e-4f09-826b-6c4c75538ef1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AXCELIS TECHNOLOGIES INC (ACLS)
CIK: 0001113232
Period of Report: 2017-11-07

Reporting Person: Bintz William J (EVP, Product Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-07 Common Stock M 28125 $12.04 Acquired 82219 Direct
2017-11-07 Common Stock S 28125 $33.33 Disposed 54094 Direct
2017-11-07 Common Stock S 9000 $33.70 Disposed 45094 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-11-07 Stock Option (right to buy) $12.04 M 28125 Disposed 2022-07-15 Common Stock (28125) Direct

Footnotes

F1: Of the shares held as of November 7, 2017, 28,675 were issuable on vesting of restricted stock units granted under the 2012 Equity Incentive Plan and are subject to forfeiture.

F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $33.25 to $33.65, inclusive. The reporting person undertakes to provide to Axcelis Technologies, Inc., any security holder of Axcelis Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $33.47 to $33.85, inclusive. The reporting person undertakes to provide to Axcelis Technologies, Inc., any security holder of Axcelis Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F4: 50,000 options were granted on July 15, 2015 and were vested as to 56.25% of the options as of October 15, 2017. Of the remaining 21,875 options held by the executive after the sales reported on this form, 3,125 options will vest on the 15th of each of July, October, January, and April until fully vested on July 15, 2019, if the officer remains in the service of the Company on such vesting dates.